Your trusted destination for CME, CPD & Medical Education across the Middle East.
The conference will provide a comprehensive review of surgical pathology, covering diagnostic histopathology, tumor classification, immunohistochemistry, molecular pathology, and digital pathology. Discussions will address organ-system pathology, challenging diagnostic cases, biomarkers, precision oncology, and emerging technologies that support accurate and clinically meaningful pathological diagnosis.
The International Surgical Pathology Conference 2027, held as the 37th Congress of the International Academy of Pathology (IAP) – Arab Division, will bring together pathologists, laboratory specialists, oncologists, surgeons, and other healthcare professionals to discuss advances in surgical pathology and diagnostic medicine. The conference will focus on contemporary approaches to the histopathological assessment and diagnosis of a broad range of neoplastic and non-neoplastic diseases. Key topics will include gastrointestinal, breast, gynecologic, urologic, pulmonary, hepatobiliary, and hematopathologic conditions, with emphasis on accurate and clinically relevant diagnosis. Advances in immunohistochemistry, molecular pathology, digital pathology, and ancillary diagnostic techniques will also be explored. Participants will have opportunities to examine challenging cases, diagnostic pitfalls, emerging biomarkers, and evolving approaches to tumor classification and grading. The program will highlight the growing role of precision medicine and integrated pathology in guiding targeted therapies and personalized patient management. Through expert presentations, case-based discussions, and scientific exchange, the conference will support continued development of knowledge and diagnostic practice in surgical pathology.
Reviewing the latest advancements and foundational importance of morphology in histopathology.
Exploring new techniques and applications of immunohistochemistry in diagnostic practice.
Evaluating and applying current standards in pathology diagnosis, reporting, and quality assurance.
Understanding the role of molecular and genomic testing in modern surgical pathology.
Identifying and utilizing predictive biomarkers to guide personalized patient treatment plans.
Evaluating the latest breakthroughs in precision medicine and their clinical implications.
Examining the integration and impact of artificial intelligence in pathology diagnostics.
Exploring new technological tools that are expanding diagnostic reach and accuracy.
Strategies for adopting and optimizing digital pathology systems in clinical settings.
Enhancing diagnostic judgment through rigorous clinicopathologic correlation.
Applying evidence-based approaches to complex surgical pathology cases through interactive discussions.
The conference is currently under approval for CME accreditation by the Department of Health (DOH).
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow